title: Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
abstract: Oxalobacter colonization of rat intestine was previously shown to promote enteric oxalate secretion and elimination, leading to significant reductions in urinary oxalate excretion (Hatch et al. Kidney Int 69: 691-698, 2006). The main goal of the present study, using a mouse model of primary hyperoxaluria type 1 (PH1), was to test the hypothesis that colonization of the mouse gut by Oxalobacter formigenes could enhance enteric oxalate secretion and effectively reduce the hyperoxaluria associated with this genetic disease. Wild-type (WT) mice and mice deficient in liver alanine-glyoxylate aminotransferase (Agxt) exhibiting hyperoxalemia and hyperoxaluria were used in these studies. We compared the unidirectional and net fluxes of oxalate across isolated, short-circuited large intestine of artificially colonized and noncolonized mice. In addition, plasma and urinary oxalate was determined. Our results demonstrate that the cecum and distal colon contribute significantly to enteric oxalate excretion in Oxalobacter-colonized Agxt and WT mice. In colonized Agxt mice, urinary oxalate excretion was reduced 50% (to within the normal range observed for WT mice). Moreover, plasma oxalate concentrations in Agxt mice were also normalized (reduced 50%). Colonization of WT mice was also associated with marked (up to 95%) reductions in urinary oxalate excretion. We conclude that segment-specific effects of Oxalobacter on intestinal oxalate transport in the PH1 mouse model are associated with a normalization of plasma oxalate and urinary oxalate excretion in otherwise hyperoxalemic and hyperoxaluric animals.
authors.affiliation: Dept. of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, USA. hatchma@ufl.edu
authors.forename: Marguerite
authors.initials: M
authors.lastname: Hatch
authors.forename: Altin
authors.initials: A
authors.lastname: Gjymishka
authors.forename: Eduardo C
authors.initials: EC
authors.lastname: Salido
authors.forename: Milton J
authors.initials: MJ
authors.lastname: Allison
authors.forename: Robert W
authors.initials: RW
authors.lastname: Freel
mesh_terms: D000818:Animals; D017920:Antiporters / Q000378:metabolism; D001692:Biological Transport; D002432:Cecum / Q000378:metabolism / Q000382:microbiology; D003106:Colon / Q000378:metabolism / Q000382:microbiology; D004195:Disease Models, Animal; D005260:Female; D005838:Genotype; D006959:Hyperoxaluria / Q000235:genetics / Q000378:metabolism / Q000382:microbiology; D006960:Hyperoxaluria, Primary; D007420:Intestine, Large / Q000378:metabolism* / Q000382:microbiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010070:Oxalates / Q000097:blood / Q000378:metabolism* / Q000652:urine; D020624:Oxalobacter formigenes / Q000254:growth & development / Q000378:metabolism*; D010641:Phenotype; D000076988:Sulfate Transporters; D013997:Time Factors; D000637:Transaminases / Q000172:deficiency / Q000235:genetics / Q000378:metabolism
chemical_list: D017920:Antiporters; D010070:Oxalates; C466900:Slc26a6 protein, mouse; D000076988:Sulfate Transporters; D000637:Transaminases; C019635:Alanine-glyoxylate transaminase